ctrl K

Watchlist Price Alert

Lexeo Therapeutics Inc. C... (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

3.71

-0.21 (-5.36%)

At close: Jun 17, 2025, 2:06 PM

Lexeo Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	654K	1.66M	518.48K
Cost of Revenue	n/a	1.84M	1.15M	13.4K	n/a
Gross Profit	n/a	-1.84M	-491K	1.64M	518.48K
Operating Income	-105.77M	-68.51M	-60.51M	-50.64M	-4.59M
Interest Income	7.56M	2.87M	1.32M	15K	n/a
Pretax Income	-98.33M	-66.39M	-59.28M	-50.62M	-5.15M
Net Income	-98.33M	-66.39M	-59.28M	-50.62M	-5.15M
Selling & General & Admin	31.68M	13.54M	12M	7.16M	787.5K
Research & Development	74.09M	53.13M	49.16M	45.12M	4.32M
Other Expenses	n/a	n/a	-2K	n/a	n/a
Operating Expenses	105.77M	66.67M	61.16M	52.29M	5.11M
Interest Expense	114K	205K	91K	n/a	147.15K
Selling & Marketing Expenses	n/a	-1.84M	n/a	-13.38K	n/a
Cost & Expenses	n/a	68.51M	61.16M	52.29M	5.11M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	31.79M	26.65M	25.17M	25.17M	25.17M
Shares Outstanding (Diluted)	31.79M	26.65M	25.17M	25.17M	25.17M
EPS (Basic)	-3.09	-2.49	-2.36	-2.01	-0.2
EPS (Diluted)	-3.09	-2.49	-2.4	-2.01	-0.2
EBITDA	-96.22M	-66.67M	-58.04M	-50.62M	-4.59M
EBIT	-98.47M	-66.19M	-59.19M	-50.62M	-4.59M
Depreciation & Amortization	n/a	1.84M	1.15M	13K	n/a